Cargando…
Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive syste...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599191/ https://www.ncbi.nlm.nih.gov/pubmed/32367193 http://dx.doi.org/10.1007/s00018-020-03540-9 |
_version_ | 1783602818445213696 |
---|---|
author | Lara-Reyna, Samuel Holbrook, Jonathan Jarosz-Griffiths, Heledd H. Peckham, Daniel McDermott, Michael F. |
author_facet | Lara-Reyna, Samuel Holbrook, Jonathan Jarosz-Griffiths, Heledd H. Peckham, Daniel McDermott, Michael F. |
author_sort | Lara-Reyna, Samuel |
collection | PubMed |
description | Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive systems and several other tissues. This debilitating condition is associated with recurrent lower respiratory tract bacterial and viral infections, as well as inflammatory complications that may eventually lead to pulmonary failure. Immune cells play a crucial role in protecting the organs against opportunistic infections and also in the regulation of tissue homeostasis. Innate immune cells are generally affected by CFTR mutations in patients with CF, leading to dysregulation of several cellular signalling pathways that are in continuous use by these cells to elicit a proper immune response. There is substantial evidence to show that airway epithelial cells, neutrophils, monocytes and macrophages all contribute to the pathogenesis of CF, underlying the importance of the CFTR in innate immune responses. The goal of this review is to put into context the important role of the CFTR in different innate immune cells and how CFTR dysfunction contributes to the pathogenesis of CF, highlighting several signalling pathways that may be dysregulated in cells with CFTR mutations. |
format | Online Article Text |
id | pubmed-7599191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-75991912020-11-10 Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations Lara-Reyna, Samuel Holbrook, Jonathan Jarosz-Griffiths, Heledd H. Peckham, Daniel McDermott, Michael F. Cell Mol Life Sci Review Cystic fibrosis (CF) is one of the most common life-limiting recessive genetic disorders in Caucasians, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CF is a multi-organ disease that involves the lungs, pancreas, sweat glands, digestive and reproductive systems and several other tissues. This debilitating condition is associated with recurrent lower respiratory tract bacterial and viral infections, as well as inflammatory complications that may eventually lead to pulmonary failure. Immune cells play a crucial role in protecting the organs against opportunistic infections and also in the regulation of tissue homeostasis. Innate immune cells are generally affected by CFTR mutations in patients with CF, leading to dysregulation of several cellular signalling pathways that are in continuous use by these cells to elicit a proper immune response. There is substantial evidence to show that airway epithelial cells, neutrophils, monocytes and macrophages all contribute to the pathogenesis of CF, underlying the importance of the CFTR in innate immune responses. The goal of this review is to put into context the important role of the CFTR in different innate immune cells and how CFTR dysfunction contributes to the pathogenesis of CF, highlighting several signalling pathways that may be dysregulated in cells with CFTR mutations. Springer International Publishing 2020-05-04 2020 /pmc/articles/PMC7599191/ /pubmed/32367193 http://dx.doi.org/10.1007/s00018-020-03540-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Lara-Reyna, Samuel Holbrook, Jonathan Jarosz-Griffiths, Heledd H. Peckham, Daniel McDermott, Michael F. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title | Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title_full | Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title_fullStr | Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title_full_unstemmed | Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title_short | Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
title_sort | dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599191/ https://www.ncbi.nlm.nih.gov/pubmed/32367193 http://dx.doi.org/10.1007/s00018-020-03540-9 |
work_keys_str_mv | AT larareynasamuel dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations AT holbrookjonathan dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations AT jaroszgriffithsheleddh dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations AT peckhamdaniel dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations AT mcdermottmichaelf dysregulatedsignallingpathwaysininnateimmunecellswithcysticfibrosismutations |